Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ownership Breakdown Pasithea Therapeutics Corp. KTTA

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders. Epidemiological data indicate neuropsychiatric disorders as being some of the most prevalent, devastating, and yet poorly treated illnesses.


Top institutional share ownership of Pasithea Therapeutics Corp.

Name Shares Shares % change Value Value % change
K2 Principal Fund, L.p. 491,797 -10.6% $497 -30.5%
Vanguard Group Inc 78,139 38.1% $79 6.8%
VEXMX - Vanguard Extended Market Index Fund Investor Shares 53,683 0.0% $54 -21.7%
State Street Corp 23,647 $24
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares 22,585 678.8% $23 633.3%
Geode Capital Management, Llc 19,726 $19
Virtu Financial LLC 14,571 $15
UBS Group AG 12,805 $13
IWC - iShares Micro-Cap ETF 8,995 5.8% $12 -26.7%
FSMAX - Fidelity Extended Market Index Fund 5,931 $5

Top institutional buyers of Pasithea Therapeutics Corp.

Name Shares % change Value % change Shares Value
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares 678.8% 633.3% 22,585 $23
Vanguard Group Inc 38.1% 6.8% 78,139 $79
Wells Fargo & Company/mn 13.1% 95 $0
IWC - iShares Micro-Cap ETF 5.8% -26.7% 8,995 $12

Top institutional sellers of Pasithea Therapeutics Corp.

Name Shares % change Value % change Shares Value
K2 Principal Fund, L.p. -10.6% -30.5% 491,797 $497

Information provided by Fintel.io